Tag: Galena Biopharma

Finance

Biotech Active Runners: Galena Biopharma Inc. (NASDAQ:GALE), Gilead Sciences (NASDAQ:GILD), Rexahn Pharmaceuticals (NYSEMKT:RNN), Inovio Pharmaceuticals Inc. (NYSEMKT:INO)

Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Oregon on behalf of holders of Galena Biopharma, Inc. (NASDAQ:GALE) securities between November 6, 2013 and February 14, 2014. Galena Biopharma Inc. (NASDAQ:GALE) stock performance was -12.42% in last session and finished the day at $2.82. Traded volume was 17.65 million shares in … Continue reading Biotech Active Runners: Galena Biopharma Inc. (NASDAQ:GALE), Gilead Sciences (NASDAQ:GILD), Rexahn Pharmaceuticals (NYSEMKT:RNN), Inovio Pharmaceuticals Inc. (NYSEMKT:INO)

Colin Pettis
FB Nasdaq FB Facebook
Finance

Healthcare Active Stocks: Inovio Pharmaceuticals (NYSEMKT:INO), Bristol-Myers Squibb (NYSE:BMY), Johnson & Johnson (NYSE:JNJ), Galena Biopharma (NASDAQ:GALE)

Inovio Pharmaceuticals, Inc. (NYSE MKT:INO) reported financial results for the fourth quarter and year ended December 31, 2013. Inovio Pharmaceuticals Inc. (NYSEMKT:INO) stock performance was -2.29% in last session and finished the day at $3.42. Traded volume was 7.95 million shares in the last session and the average volume of the stock remained 8.89 million shares. The beta of the stock remained 3.55. Inovio Pharmaceuticals … Continue reading Healthcare Active Stocks: Inovio Pharmaceuticals (NYSEMKT:INO), Bristol-Myers Squibb (NYSE:BMY), Johnson & Johnson (NYSE:JNJ), Galena Biopharma (NASDAQ:GALE)

John Bellich
FB Nasdaq FB Facebook
Finance

Healthcare Movers: Intercept Pharmaceuticals Inc. (NASDAQ:ICPT), Pernix Therapeutics (NASDAQ:PTX), Galena Biopharma (NASDAQ:GALE), Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)

Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) is lower after the company reported mixed Q4 and full-year 2013 earnings, as well as releasing results for its Phase 3 POISE trial. Shares are now down 10.71% at $412.75, but are still at the higher end of its 52-week range of $30.38 – $497.00 On Friday, Intercept (NASDAQ:ICPT) reported a loss per share of $0.64, compared to a loss of … Continue reading Healthcare Movers: Intercept Pharmaceuticals Inc. (NASDAQ:ICPT), Pernix Therapeutics (NASDAQ:PTX), Galena Biopharma (NASDAQ:GALE), Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)

Mark DeFrance
Gilead Sciences GILD NASDAQ:GILD
BioTech

Biotech Most Volatile: Arca Biopharma (NASDAQ:ABIO), Galena Biopharma (NASDAQ:GALE), Progenics Pharmaceuticals (NASDAQ:PGNX), AVEO Pharmaceuticals (NASDAQ:AVEO)

ARCA biopharma, Inc. (NASDAQ:ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases announced that Dan Mitchell has been appointed to the Company’s Board of Directors. Arca Biopharma Inc. (NASDAQ:ABIO) stock performance was -2.31% in last session and finished the day at $2.11. Traded volume was 3.15 million shares in the last session and the average volume of the stock remained 862,287.00 shares. The beta … Continue reading Biotech Most Volatile: Arca Biopharma (NASDAQ:ABIO), Galena Biopharma (NASDAQ:GALE), Progenics Pharmaceuticals (NASDAQ:PGNX), AVEO Pharmaceuticals (NASDAQ:AVEO)

Kevin Long
BioTech

Biotech Losers: CytRx Corporation (NASDAQ:CYTR), Galena Biopharma (NASDAQ:GALE), Arena Pharmaceuticals (NASDAQ:ARNA), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

CytRx Corporation (NASDAQ:CYTR) reported financial results for the 12 months ended December 31, 2013, and also provided an overview of recent accomplishments and upcoming milestones for its clinical development programs. CytRx Corporation (NASDAQ:CYTR) stock performance was -12.76% in last session and finished the day at $4.17. Traded volume was 11,065,087 million shares in the last session and the average volume of the stock remained 3.51 … Continue reading Biotech Losers: CytRx Corporation (NASDAQ:CYTR), Galena Biopharma (NASDAQ:GALE), Arena Pharmaceuticals (NASDAQ:ARNA), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

Chris Lewis
BioTech

Healthcare Active runners: Zogenix (NASDAQ:ZGNX), Boston Scientific (NYSE:BSX), Galena Biopharma (NASDAQ:GALE), Gilead Sciences (NASDAQ:GILD)

Officials with Zogenix Inc. (NASDAQ:ZGNX), the San Diego-based maker of Zohydro, did not return a message seeking comment about the drug. The company is marketing the drug as the first extended-release hydrocodone pain reliever without acetaminophen, which can cause liver failure if taken in excess. Zogenix, Inc. (NASDAQ:ZGNX) stock performance was -14.18% in last session and finished the day at $3.84. Traded volume was 9.38million … Continue reading Healthcare Active runners: Zogenix (NASDAQ:ZGNX), Boston Scientific (NYSE:BSX), Galena Biopharma (NASDAQ:GALE), Gilead Sciences (NASDAQ:GILD)

Kristen Barton